Awakn Life Sciences Corp.
AWKNF
$0.065
-$0.0147-18.44%
OTC PK
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 42.10K | 60.70K | 71.20K | 64.90K | 398.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 42.10K | 60.70K | 71.20K | 64.90K | 398.70K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 42.10K | 60.70K | 71.20K | 64.90K | 48.70K |
| SG&A Expenses | 1.27M | 1.44M | 2.09M | 2.35M | 2.70M |
| Depreciation & Amortization | 13.70K | 15.00K | 14.30K | 13.50K | 12.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.82M | 1.99M | 2.68M | 2.98M | 3.31M |
| Operating Income | -1.78M | -1.93M | -2.60M | -2.92M | -3.27M |
| Income Before Tax | -1.91M | -2.12M | -2.72M | -2.73M | -2.33M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.91 | -2.12 | -2.72 | -2.73 | -2.33 |
| Earnings from Discontinued Operations | 282.60K | 282.60K | -166.30K | -995.50K | -2.43M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | 67.30K | 67.30K |
| Net Income | -1.63M | -1.83M | -2.88M | -3.65M | -4.69M |
| EBIT | -1.78M | -1.93M | -2.60M | -2.92M | -3.27M |
| EBITDA | -1.77M | -1.92M | -2.59M | -2.90M | -3.18M |
| EPS Basic | -0.05 | -0.06 | -0.09 | -0.13 | -0.18 |
| Normalized Basic EPS | -0.03 | -0.04 | -0.05 | -0.06 | -0.06 |
| EPS Diluted | -0.05 | -0.06 | -0.09 | -0.13 | -0.18 |
| Normalized Diluted EPS | -0.03 | -0.04 | -0.05 | -0.06 | -0.06 |
| Average Basic Shares Outstanding | 139.86M | 135.30M | 130.13M | 117.93M | 108.03M |
| Average Diluted Shares Outstanding | 139.86M | 135.30M | 130.13M | 117.93M | 108.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |